This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Forward Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Chris De Savi: Innovator in TNF-α Modulation
Introduction
Chris De Savi is a notable inventor based in Stow, MA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of TNF-α activity. His work focuses on developing inhibitors that can potentially treat various diseases and disorders.
Latest Patents
Chris De Savi holds a patent for "Modulators of TNF-α activity." This patent includes inhibitors of TNFα, pharmaceutical compositions comprising these inhibitory compounds, and methods for utilizing them in the treatment of diseases or disorders. His innovative approach aims to provide new therapeutic options for patients.
Career Highlights
Chris is currently associated with Forward Therapeutics, Inc., where he continues to advance his research and development efforts. His expertise in pharmaceutical compositions and their applications has positioned him as a valuable asset in the industry.
Collaborations
Chris collaborates with various professionals in his field, including his coworker Toufike Kanouni. Together, they work on innovative solutions that aim to improve patient outcomes through advanced therapeutic strategies.
Conclusion
Chris De Savi's contributions to the modulation of TNF-α activity highlight his commitment to advancing medical science. His work not only showcases his inventive spirit but also holds promise for future therapeutic developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile